Clal Insurance Enterprises Holdings Ltd. (TLV:CLIS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 25,240
+110 (0.44%)
Apr 28, 2026, 5:24 PM IDT
TLV:CLIS Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Premiums & Annuity Revenue | 8,837 | 8,391 | 9,495 | 9,844 | 9,012 | Upgrade
|
| Total Interest & Dividend Income | 5,507 | 4,110 | 3,660 | 2,757 | 2,088 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 5,571 | -6,948 | 11,766 | Upgrade
|
| Non-Insurance Activities Revenue | 1,740 | 1,554 | 1,083 | - | - | Upgrade
|
| Other Revenue | 190 | 180 | 390 | 383 | 339 | Upgrade
|
| Total Revenue | 17,124 | 15,040 | 21,458 | 7,234 | 24,980 | Upgrade
|
| Revenue Growth (YoY) | 13.86% | -29.91% | 196.63% | -71.04% | 69.83% | Upgrade
|
| Policy Benefits | 6,852 | 6,566 | 15,391 | 3,741 | 20,273 | Upgrade
|
| Policy Acquisition & Underwriting Costs | - | - | 2,084 | 1,970 | 1,799 | Upgrade
|
| Selling, General & Administrative | - | - | 1,604 | 1,152 | 1,160 | Upgrade
|
| Provision for Bad Debts | 169 | 216 | 411 | - | - | Upgrade
|
| Non-Insurance Activities Expense | 1,522 | 1,219 | 905 | - | - | Upgrade
|
| Other Operating Expenses | 1,783 | 1,561 | 40 | 18 | 9 | Upgrade
|
| Reinsurance Income or Expense | -687 | -758 | - | - | - | Upgrade
|
| Total Operating Expenses | 11,013 | 10,320 | 20,452 | 6,896 | 23,265 | Upgrade
|
| Operating Income | 6,111 | 4,720 | 1,006 | 338 | 1,715 | Upgrade
|
| Interest Expense | -852 | -779 | -651 | -213 | -219 | Upgrade
|
| Earnings From Equity Investments | 21 | 14 | 8 | 3 | 29 | Upgrade
|
| Currency Exchange Gain (Loss) | -6 | -5 | 12 | 27 | -9 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,885 | -1,665 | -2 | 1 | - | Upgrade
|
| EBT Excluding Unusual Items | 3,389 | 2,285 | 373 | 156 | 1,516 | Upgrade
|
| Asset Writedown | - | - | -26 | 39 | 82 | Upgrade
|
| Other Unusual Items | - | - | - | - | -17 | Upgrade
|
| Pretax Income | 3,389 | 2,285 | 347 | 195 | 1,581 | Upgrade
|
| Income Tax Expense | 1,104 | 739 | 124 | 68 | 494 | Upgrade
|
| Earnings From Continuing Ops. | 2,285 | 1,546 | 223 | 127 | 1,087 | Upgrade
|
| Minority Interest in Earnings | -7 | -6 | -3 | -6 | -5 | Upgrade
|
| Net Income | 2,278 | 1,540 | 220 | 121 | 1,082 | Upgrade
|
| Net Income to Common | 2,278 | 1,540 | 220 | 121 | 1,082 | Upgrade
|
| Net Income Growth | 47.92% | 600.00% | 81.82% | -88.82% | 146.65% | Upgrade
|
| Shares Outstanding (Basic) | 80 | 79 | 78 | 74 | 68 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 79 | 79 | 74 | 68 | Upgrade
|
| Shares Change (YoY) | 4.31% | 0.56% | 6.33% | 9.72% | 0.14% | Upgrade
|
| EPS (Basic) | 28.57 | 19.47 | 2.83 | 1.64 | 16.00 | Upgrade
|
| EPS (Diluted) | 27.47 | 19.38 | 2.79 | 1.62 | 15.97 | Upgrade
|
| EPS Growth | 41.74% | 594.62% | 72.22% | -89.86% | 146.45% | Upgrade
|
| Free Cash Flow | 2,450 | 1,536 | -4,344 | -2,609 | 7,061 | Upgrade
|
| Free Cash Flow Per Share | 29.55 | 19.33 | -54.96 | -35.10 | 104.23 | Upgrade
|
| Operating Margin | 35.69% | 31.38% | 4.69% | 4.67% | 6.87% | Upgrade
|
| Profit Margin | 13.30% | 10.24% | 1.03% | 1.67% | 4.33% | Upgrade
|
| Free Cash Flow Margin | 14.31% | 10.21% | -20.24% | -36.07% | 28.27% | Upgrade
|
| EBITDA | 6,188 | 4,785 | 1,065 | 660 | 2,040 | Upgrade
|
| EBITDA Margin | 36.14% | 31.81% | 4.96% | 9.12% | 8.17% | Upgrade
|
| D&A For EBITDA | 77 | 65 | 59 | 322 | 325 | Upgrade
|
| EBIT | 6,111 | 4,720 | 1,006 | 338 | 1,715 | Upgrade
|
| EBIT Margin | 35.69% | 31.38% | 4.69% | 4.67% | 6.87% | Upgrade
|
| Effective Tax Rate | 32.58% | 32.34% | 35.73% | 34.87% | 31.25% | Upgrade
|
| Revenue as Reported | - | - | 21,464 | 7,329 | 25,057 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.